Benedito A Carneiro Selected Research

Benedito A Carneiro Research Topics

Disease

42	Neoplasms (Cancer) 05/2024 - 08/2015
10	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2018
6	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 03/2012
5	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2006
3	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2024 - 06/2023
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 04/2018
3	Adenocarcinoma 01/2024 - 03/2006
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 03/2006
3	Leukemia 01/2023 - 03/2006
3	Carcinogenesis 12/2022 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 08/2007
2	Anemia 05/2024 - 12/2023
2	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 01/2023
2	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 01/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 08/2015
2	Microsatellite Instability 01/2024 - 01/2023
2	Disease Progression 01/2024 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2023 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2022
2	Neutropenia 01/2022 - 03/2012
2	Fatigue 01/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2021 - 07/2016
2	Small Cell Carcinoma 01/2021 - 01/2018
2	Adrenocortical Carcinoma 12/2019 - 07/2016
2	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2007
2	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 09/2015
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Testicular Neoplasms (Testicular Cancer) 12/2023
1	Hematologic Neoplasms (Hematological Malignancy) 11/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2022
1	Nausea 01/2022
1	Thrombocytopenia 3 01/2022
1	Febrile Neutropenia 01/2022
1	Glioma (Gliomas) 01/2022

Drug/Important Bio-Agent (IBA)

8	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2016
7	Proteins (Proteins, Gene)FDA Link 02/2023 - 11/2015
6	Glycogen Synthase (Synthase I)IBA 11/2023 - 01/2017
5	Phosphotransferases (Kinase)IBA 05/2024 - 01/2016
3	Glycogen Synthase Kinase 3IBA 06/2023 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2016
3	Tyrosine Kinase InhibitorsIBA 01/2016 - 08/2015
2	LigandsIBA 02/2024 - 01/2022
2	Granzymes (Granzyme)IBA 02/2024 - 06/2023
2	CytokinesIBA 01/2024 - 02/2023
2	AntigensIBA 01/2024 - 01/2018
2	TIC10 compoundIBA 01/2023 - 12/2021
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2017
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2022 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2022 - 12/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 12/2019
2	AndrogensIBA 01/2021 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	ParaffinIBA 01/2021 - 11/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 03/2006
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 03/2012
2	B7-H1 AntigenIBA 01/2021 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2020 - 10/2016
2	Anaplastic Lymphoma KinaseIBA 04/2018 - 01/2018
2	Gemcitabine FDA Link 09/2017 - 08/2007
2	IodineIBA 01/2016 - 09/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 09/2015
2	lenvatinibIBA 01/2016 - 09/2015
1	monalizumabIBA 02/2024
1	durvalumabIBA 02/2024
1	ChemokinesIBA 02/2024
1	LipidsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 12/2023
1	EnzymesIBA 01/2023
1	Tiopronin (Thiola)FDA Link 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	navitoclaxIBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	venetoclaxIBA 01/2023
1	Pemetrexed (MTA)FDA Link 01/2023
1	PlatinumIBA 12/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	ribociclibIBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	Filgrastim (Neupogen)FDA Link 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Caspase 3 (Caspase-3)IBA 12/2021
1	Therapeutic UsesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021

Therapy/Procedure

31	Therapeutics 01/2024 - 03/2006
11	Drug Therapy (Chemotherapy) 01/2024 - 06/2006
7	Immunotherapy 01/2021 - 04/2016
4	Castration 01/2022 - 01/2018
1	Drug Tapering 05/2024
1	Aftercare (After-Treatment) 01/2023
1	Immunomodulation 01/2022